Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

The Head and Neck Radiation Oncology Group (GORTEC) announced significant improvement in disease-free survival for locally ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that leave minority patients at a disadvantage due to their under-representation in ...

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to ...

Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 ...

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial ...

TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene ...

Champions Oncology (CSBR) announced advancements in its bioanalytical services portfolio, specifically, expanding its capabilities with the integration of multiple global Cytek Aurora flow cytometers ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple ...